Asset Details
Do you wish to reserve the book?
Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen
Do you wish to request the book?
Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Testosterone for Low Libido in Postmenopausal Women Not Taking Estrogen
2008
Overview
In this double-blind, placebo-controlled, 52-week trial among postmenopausal women not receiving estrogen therapy, treatment with a patch delivering 300 μg of testosterone per day resulted in a significant although modest increase in the 4-week frequency of satisfying sexual episodes (1.4 more episodes per month), but the women were also subject to more adverse events, including androgenic side effects.
In postmenopausal women not receiving estrogen therapy, treatment with a patch delivering 300 '1;g of testosterone per day resulted in a significant although modest increase in the 4-week frequency of satisfying sexual episodes.
The literature suggests that the prevalence of sexual problems among women ranges from 9 to 43%.
1
–
4
Among these women, hypoactive sexual desire disorder is a commonly reported, symptom-driven condition characterized by a decrease or absence of interest in sexual activity, causing distress.
5
Decreased libido is common after natural menopause
6
,
7
and bilateral oophorectomy.
8
–
10
Several studies have shown the efficacy and short-term safety of a transdermal patch delivering 300 μg of testosterone per day for the treatment of hypoactive sexual desire disorder in women who have undergone either surgically induced or natural menopause and who use concomitant estrogen.
11
– . . .
Publisher
Massachusetts Medical Society
Subject
/ Androgens - administration & dosage
/ Biological and medical sciences
/ Breast Neoplasms - epidemiology
/ Female
/ Hirsutism - chemically induced
/ Humans
/ Postmenopause - drug effects
/ Sexual Dysfunction, Physiological - drug therapy
/ Studies
/ Testosterone - administration & dosage
/ Testosterone - adverse effects
/ Testosterone - therapeutic use
/ Women
